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Abstract
Nuclear factor of activated T (NFAT) cells is a family of transcription factors important for the regulation of cytokine expression by CD4+
T cells. Whilst a number of studies have examined NFAT activity of in vitro generated CD4+ T helper (Th)1 and Th2 cells, regulation of NFAT
during in vivo immune responses has yet to be elucidated. We show that NFAT activity in CD4+ T cells peaked at early time-points in the
draining mediastinal lymph node of mice infected with influenza A (Flu) or Nippostrongylus brasiliensis (Nb). In contrast, low NFAT tran-
scriptional activity was detected in CD4+ T cells isolated from the lung of either Flu or Nb infected mice, despite a greater proportion of
cytokine-producing cells being present at this site. These findings indicate that the activation status and tissue microenvironment of effector
CD4+ T cells can determine their requirement for NFAT-mediated transcription.
© 2005 Elsevier SAS. All rights reserved.
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1. Introduction
Although nuclear factor of activated T (NFAT) was origi-
nally described as a transcription factor present in the nucleus
of activated T cells, it is now clear that NFAT represents a
family of transcription factors which are expressed in other
cells of the lymphoid system as well as non-lymphoid cells
(reviewed by [1,2]). This family of proteins is characterised
by the presence of a Rel-homology domain and a calcineurin
binding domain. Four members of the family have been iden-
tified, NFATc1, NFATc2, NFATc3 and NFATc4. NFATc1 and
NFATc2 are the predominant members in T cells, but they
are also expressed in a large variety of tissues including heart,
neurons, vascular cells, chondriocytes, and adipocytes [3–7].
NFAT transcription factors are believed to be present in
the cytoplasm and translocated to the nucleus in response to
calcium signals [8]. The accumulation of NFAT in the nucleus
is the result of nuclear import promoted by calcineurin-
mediated dephosphorylation, and nuclear export promoted by
phosphorylation mediated by several kinases (e.g. GSK3,
JNK, p38 MAP kinase, casein-kinase II, MKK1) [9–14]. In
the nucleus, NFAT family members associate with other
nuclear transcription factors (e.g. JUN, GATA4, IRF, C/EBP)
depending on the cell type, to mediate transcription of spe-
cific genes including cytokine and cytokine receptor genes
[15–17]. In addition to the regulation of their nuclear locali-
sation by phosphorylation/dephosphorylation, NFAT mem-
bers can also be regulated at the level of gene expression. The
expression of NFATc1 isoforms is regulated during the acti-
vation of CD4+ T cells by the usage of different promoters
and corresponding polyadenylation signals [18–20].
NFATc2 expression is also upregulated during the activation
of CD4+ T cells and by IL-6-mediated signals [21].
In addition to nuclear transport, phosphorylation can also
regulate NFAT activity in a different manner. Although less
well established, there are some studies indicating that phos-
phorylation can regulate the ability of NFAT members to
mediate transcription once they are in the nucleus. PIM-1-
mediated phosphorylation has been shown to be important
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for the transactivation activity of NFATc1 [22]. The mecha-
nism remains unclear, but it is possible that phosphorylation
can regulate the association of NFAT to other transcription
factors or co-activators. Thus, several regulatory mecha-
nisms control NFAT activity.
A number of studies have shown the regulation of NFAT
nuclear accumulation and transcription during activation of
naïve CD4+ T cells and differentiation of these cells into effec-
tor Th1 and Th2 CD4+ T cells in vitro. It has been shown that
NFAT transcriptional activity is rapidly induced to higher lev-
els in effector cells compared to naïve CD4+ T cells follow-
ing activation [23]. Whilst no difference in nuclear accumu-
lation of NFAT has been observed during the differentiation
of Th1 and Th2 cells [24], higher NFAT transcriptional activ-
ity is triggered in Th2 cells compared with that triggered in
Th1 cells in vitro [23]. To date, no studies have tried to address
the regulation of NFAT activity in effector CD4+ T cells dur-
ing in vivo Th1 and Th2 immune responses.
In the present study, we have examined the regulation of
NFAT activity during the activation of effector T helper cells
generated in vivo in response to influenza virus (Th1) or Nip-
postrongylus brasiliensis (Th2). NFAT transcriptional activ-
ity was found at maximal levels within CD4+ T cells isolated
from the draining mediastinal lymph node (MedLN) of
infected mice, yet activity was decreased as the ability to pro-
duce effector cytokines was gained. NFAT activity in T cells
isolated from the lung was consistently reduced in compari-
son to levels observed in MedLN cells. This was in direct
contrast to the increased capacity of these cells for produc-
tion of the effector cytokines IFN-c and IL-4. These data were
supported by analysis of NFAT DNA binding activity by
EMSA in which NFAT activity was detected in both LN and
lung samples, but was consistently decreased in those cells
isolated from the lung.
2. Materials and methods
2.1. Mice
All mice were bred and maintained at the Animal Facility
of the Wellington School of Medicine. NFAT-luciferase
reporter transgenic mice have been1 described previously [23].
These mice were backcrossed at least six times onto the
C57BL/6 background, and maintained by breeding female
transgenic mice to male C57BL/6 mice. All experimental ani-
mal procedures used in this study were approved by the Well-
ington School of Medicine Animal Ethics Committee, and
carried out in accordance with the guidelines set by the Uni-
versity of Otago, New Zealand.
2.2. Influenza A and N. brasiliensis infections
The A/HKx31 (H3N2) influenza A virus was maintained
as described [25]. For Flu infection, mice were anaesthetised
by intraperitoneal injection (i.p.) of a mixture of ketamine
and xylazine (Phoenix,Auckland, New Zealand) and 12 HAU
of virus in a 30 µl volume of PBS was administered by intra-
nasal inoculation (i.n.). The preparation of Nb third stage lar-
vae (L3) and the subcutaneous inoculation of L3 were per-
formed as described previously [26]. Mice were infected with
750 L3, then subjected to a second infection of 1000 L3
8 weeks later.
2.3. CD4+ T cell isolation
For the preparation of mononuclear cells from the lung,
mice were sacrificed and the lungs perfused via the heart right
ventricle with approximately 5 ml PBS to remove circulating
blood. Minced lung tissue was incubated for 1 h in complete
IMDM containing 2.4 mg/ml collagenase type II (Gibco-
BRL) and 0.1% DNase 1 (Sigma), and mononuclear cells
purified by gradient centrifugation over 30% Percoll®. Com-
plete IMDM (cIMDM) consisted of IMDM (Sigma, Chemi-
cal Co., St. Louis, MO, USA) with 5% FCS (Gibco BRL,
Life Tech, Auckland, New Zealand), 2 mM glutamine
(Sigma), 1% penicillin–streptomycin (Sigma) and 5 × 10–
5 M 2-ME (Sigma). MedLN cell suspensions were prepared
by squeezing the lymph nodes between two layers of gauze.
For all samples CD4+ T cells were isolated by labelling with
biotin labelled anti-CD4 mAb (GK1.5), followed by purifi-
cation using Strepdavidin MicroBeads® (MACs Reagents,
Miltenyi Biotec, Germany) as per manufacturer’s instruc-
tions. Purity of CD4+ T cells was 80–95%.
2.4. Measurements of luciferase content
CD4+ T cells purified from infected or non-infected mice
were re-stimulated on anti-CD3 mAb (2C11, 10 g/ml) coated
24 well plates in supplemented IMDM plus 20 U/ml recom-
binant human IL-2 and anti-CD28 mAb for 20 h. Harvested
cells were counted and samples adjusted to contain between
5 × 105 and 1 × 106 live cells. Cells were washed twice in
PBS then lysed in lysis buffer (Luciferase Assay, Promega,
Madison, WI) for 30 min at RT. Lysate was centrifuged and
supernatant analysed using Luciferase Reagent (Promega).
Measurements were made for 10 s using a luminometer (TD
20/20, Turner designs, Sunnyvale, CA). Three measurements
were made of each sample, with background readings
of ≤ 0.05. Luciferase values were averaged, corrected to rep-
resent measurements for 1 × 106 cells, then expressed as the
fold increase in activity determined for CD4+ T cells isolated
from infected versus non-infected mice.
2.5. Intracellular cytokine staining and FACs analysis
CD4+ T cells purified from the lung or MedLN were cul-
tured at a concentration of 1 × 106 cells per well in 24 well
plates (Falcon) for a total of 20 h as indicated. All cells were
incubated with or without plate bound anti-CD3 mAb in a
total volume of 1 ml of cIMDM plus IL-2 and anti-
CD28 mAb. Monensin (Calbiochem-Novabiochem Corp., La
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Jolla, CA, USA) was added at a final concentration of 2 mM
for the last 3–4 h of culture. At the end of the culture period
cells were harvested, washed once in PBS buffer, then fixed
in 4% paraformaldehyde (Sigma) for 15 min at RT. Fixed
cells were surface stained with anti-CD4-Biotin mAb fol-
lowed by SA-PerCP (Pharmingen) then subjected to intrac-
ellular cytokine staining in saponin buffer (PBS, 10 mM
Hepes, 0.1% saponin, 0.1% BSA, 0.02% Na azide) for 30 min
at RT. Anti-IL-4-APC and anti-IFN-c-PE were obtained from
Pharmingen and used at a 1:100 dilution. Flow cytometric
analysis was performed on a FACSort (Becton Dickinson)
using the CellQuest software.
2.6. Nuclear extracts and electrophoretic mobility shift
assay (EMSA)
CD4+ T cells were isolated from mice at day 4 following
infection then stimulated on anti-CD3 coated plates in the
presence of anti-CD28 and IL-2 for 20 h. At the end of cul-
ture period nuclear proteins were extracted as previously
described [27]. Binding reactions were carried out using 1.5 µg
of nuclear proteins and a 32P-dCTP-end labelled double
stranded oligonucleotide probe containing a NFAT binding
site from the proximal IL-4 promoter 5′-GTA ATA AAA TTT
TCC AAT GTA AA-3′ [28] or a CREB binding site from the
somatostatin gene 5′-GAT CTC TCT GAC AGC CAA GGA
GGA GGC C-3′ [29]. One millilitre of anti-NFATc1 Ab
(Upsate Biotechnology, Lake Placid, NY), or anti-NFATc2
mAb (Affinity BioReagents, Golder, CO), was present in the
binding reactions for super-shift analysis. Samples were elec-
trophoresed under non-denaturing conditions and exposed to
film for autoradiography.
3. Results
3.1. NFAT-driven transcription is increased in CD4+
T cells early following influenza A virus infection,
but decreases as effector function is gained
Flu infects the epithelial cells lining the airways [30], and
in mice induces a strong immune response typically resulting
in the eradication of virus by day 10 post-infection (unpub-
lished data from our laboratory). Protective immunity is
largely due to the action of neutralising antibodies and
cytolytic CD8+ T cells, but is paralleled by the accumulation
of effector Th1 cells in the MedLN and lung [31,32]. IFN-c
production plays an important role in anti-viral immunity as
demonstrated by a dramatically delayed clearance of the virus
in mice treated with anti-IFN-c antibodies [33,34].
Infection of C57BL/6 mice with Flu led to an increased
number of CD4+ T cells present in the MedLN from day 4,
and the lung from day 8 (Fig. 1A). These cells developed the
capacity to produce IFN-c by day 8, with increased numbers
of IFN-c-producing CD4+ T cells detected at day 12 post-
infection (Fig. 1B). The proportion of effector CD4+ Th1 cells
(as determined by IFN-c production) present in the lung was
found to increase from day 8 and was much greater than that
observed in the draining MedLN (Fig. 1B).
We sought to analyse the utilisation of NFAT by CD4+ T
cells following Flu infection. For this purpose we employed
the use of transgenic mice in which NFAT-driven transcrip-
tion can be determined by the expression of a luciferase
Fig. 1. NFAT transcriptional activity in CD4+ T cells isolated from the
MedLN or lung of influenza A infected mice. C57BL/6 (A and B) or NFAT-
luciferase reporter transgenic mice (C) were given an i.n. inoculation 12 HAU
of influenza A virus in a 30 µl volume. (A) At the indicated time-points
following infection, lymphocyte suspensions from the MedLN or lung were
counted and examined for CD4 expression. Plots show fold increase in the
total numbers of CD4+ T cells in infected versus naïve mice. (B) Remaining
cells were re-stimulated on plate bound anti-CD3 for 20 h, with monensin
added for the final 3–4 h of culture. Cells were then fixed and subjected to
intracellular cytokine staining as described in Section 2. Plots indicate the
proportion of CD4+ T cells producing IFN-c. (C) CD4+ T cells isolated
from MedLN or lung of naïve or Flu infected NFAT-luciferase reporter trans-
genic mice were re-stimulated on plate bound anti-CD3 for 20 h, and luci-
ferase activity determined as described. Values indicate fold increase in abso-
lute luminometer readings per 1 × 106 cells isolated from infected versus
naïve mice. The data shown represents mean ± S.D. of two to four indivi-
dual animals from one representative experiment. Similar results were obtai-
ned from three separate experiments.
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reporter gene. These mice have been used extensively for
analysis of NFAT-driven transcriptional activity in different
tissues [21,23,35,36]. For detection of luciferase expression,
CD4+ T cells obtained from naïve or Flu infected mice were
re-stimulated in vitro for 20 h with anti-CD3 mAb. A greater
than 20-fold increase in NFAT transcriptional activity was
detected in CD4+ T cells isolated from the MedLN at day
4 after Flu infection compared to naïve control mice (Fig. 1C).
However, this increase was short-lived, and no longer appar-
ent by day 8 post-infection (Fig. 1C). No NFAT activity could
be detected in lung CD4+ T cells at any time-point examined
(Fig. 1C), despite large numbers of these cells being capable
of producing IFN-c (Fig. 1B). The lack of T cell luciferase
expression in these assays was not a consequence of poor
activation as the culture supernatant was found to contain
increased levels of IFN-c indicating normal effector function
(data not shown).
3.2. Increased NFAT-mediated transcription in lymph node
resident effector CD4+ T cells compared to lung resident
cells following N. brasiliensis infection
We next examined NFAT-driven transcriptional activity in
the MedLN and lung of Nb infected mice. Nb is a helminth
parasite that penetrates its host via the skin, then migrates
into the vasculature, becoming trapped within the lungs by
24–48 h post-infection. Larvae are coughed up and swal-
lowed 48–72 h after inoculation and mature in the jejunum
into egg-laying adults by days 5–6 [37]. Mice are protected
against a challenge infection with Nb [38], however some
worms do make it to the lung and challenge infection results
in a rapid and marked Th2 cell response at this site, which is
greater than that seen following primary infection (unpub-
lished observations) and characterised by IL-4 and IL-5 pro-
duction and eosinophilia. We therefore used a challenge infec-
tion with Nb to examine IL-4 production in CD4+ T cells
isolated from the MedLN or lung (Fig. 2A). Cells producing
IL-4 could be detected by day 4, with cytokine-producing
cell numbers peaking at day 6 in both tissues (Fig. 2B). As
seen following Flu infection, the proportion of CD4+ T cells
capable of producing effector cytokines (IL-4) was found to
be much greater in the lung than the MedLN (Fig. 2B).
Analysis of the luciferase content of CD4+ T cells from
Nb infected mice showed that NFAT transcriptional activity
increased in CD4+ T cells isolated from the MedLN, with
activity peaking at day 4 post-infection (Fig. 2C). Effector
CD4+ T cells isolated from the lung only exhibited NFAT
transcriptional activity at day 4 post-infection, and this was
reduced in comparison to the activity detected in MedLN cells
(Fig. 2C).
3.3. NFAT DNA binding activity is greater in MedLN than
lung CD4+ Th1 and Th2 cells isolated from mice infected
with influenza A virus or N. brasiliensis, respectively
In parallel we examined the NFAT DNA binding activity
in CD4+ T cells isolated from Flu or Nb infected
C57BL/6 mice. CD4+ T cells were isolated from the MedLN
or lung at days 4–5 post-infection and re-stimulated on anti-
CD3 coated plates in the presence of anti-CD28 and IL-2 for
20 h. At the end of culture period nuclear proteins were iso-
lated and NFAT DNA binding activity was determined by
EMSA. Protein loading was controlled by concurrent exami-
nation of CREB DNA binding activity. NFAT DNA binding
activity was found to be present in nuclear extracts of both
MedLN and lung CD4+ T cells isolated from mice infected
with Flu (Fig. 3A) or Nb (Fig. 3B). However, in correlation
with the results obtained for the regulation of NFAT-mediated
Fig. 2. NFAT transcriptional activity by CD4+ T cells isolated from the
MedLN or lung of N. brasisliensis infected mice. C57BL/6 (A and B) or
NFAT-luciferase reporter transgenic mice (C) were given a primary s.c. ino-
culation with 750Nb L3, followed by a secondary s.c. inoculation of 1000 L3
8 weeks later. At the indicated time-points following secondary infection
the: (A) fold increase in total numbers of CD4+ T cells in infected versus
naïve mice, (B) proportion of CD4+ T cells producing IL-4 and (C) fold
increase in absolute luminometer readings per 1 × 106 cells isolated from
infected versus naïve mice, were determined as described in Fig. 1. The data
shown represents mean ± S.D. of three to five individual animals from one
representative experiment. Similar results were obtained from two separate
experiments.
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transcription, NFAT DNA binding was diminished in those
CD4+ T cells isolated from the lung as compared to the
MedLN (Fig. 3A, B). By performing supershift analysis we
determined that this difference was apparent for both
NFATc1 and NFATc2, which are the predominant NFAT fam-
ily members present in T cells.
4. Discussion
We have observed that NFAT is transcriptionally active to
a high degree in MedLN CD4+ T cells early following influ-
enza or Nb infections, respectively. However, in both infec-
tion models, NFAT-driven transcription decreased as the cells
become more activated. Moreover, effector CD4+ cells iso-
lated from the lung of Flu infected mice did not express detect-
able luciferase levels, yet were capable of IFN-c production.
In parallel NFAT-mediated transcription was decreased in
effector CD4+ cells isolated from the lung compared to the
draining LN of Nb infected mice.
Taken together, these data suggest that the activation of
CD4+ T cells in the lymphoid tissues requires greater NFAT-
mediated gene transcription, than does effector function of T
cells residing in the lung. Thus, NFAT activity does not nec-
essarily correlate with the degree of effector cytokine produc-
tion. This may indicate that T cells require less NFAT-
mediated transcription for cytokine production once they have
undergone the process of chromatin remodelling and induc-
tion of cytokine gene transcription following initial encoun-
ter with antigen in the draining lymphoid tissues.
In a previous study we identified crucial differences in the
ability of effector Th2 cells to proliferate within lymph node
versus lung tissues following antigenic stimulation in vivo
[39]. Our current observations indicate that, as for prolifera-
tion, NFAT-driven gene transcription is differentially regu-
lated within lymphoid tissue and lung micro-environments.
This supports our earlier hypothesis that effector CD4+ T cells
are likely to receive varied signalling inputs when located
within different organs. Such differences may arise through
altered levels of antigen, co-stimulatory signals or through
the presence of specific regulatory factors present within
peripheral tissues.
In summary, we have observed that NFAT-mediated gene
transcription was apparent at a greater level during the early
stages of CD4+ T cell activation, and was active to a higher
degree in T cells located within the draining lymphoid tis-
sues compared to those cells present in the lung. These data
highlight the important roles activation status and tissue
microenvironment can play in the regulation of CD4+ T cell
function, and have important implications for the use of NFAT
inhibitors in treating pathological inflammation within periph-
eral tissues.
Acknowledgments
The authors thank the personnel of the animal facility of
the Wellington School of Medicine for animal husbandry. This
work was supported by grants from the Marsden Fund, Royal
Society of New Zealand, Wellington Medical Research Foun-
dation and the Wellcome Trust, UK.
References
[1] G.R. Crabtree, E.N. Olson, NFAT signalling: choreographing the
social lives of cells, Cell (2002) 109 (Suppl.).
[2] A. Rao, C. Luo, P.G. Hogan, Transcription factors of the NFAT family:
regulation and function, Annu. Rev. Immunol. 15 (1997) 707–747.
[3] J.L. de la Pompa, L.A. Timmerman, H. Takimoto, H. Yoshida,
A.J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B.L. Lang-
ille, G.R. Crabtree, T.W. Mak, Role of the NF-ATc transcription factor
in morphogenesis of cardiac valves and septum, Nature 392 (1998)
182–186.
[4] I.A. Graef, F. Chen, L. Chen, A. Kuo, G.R. Crabtree, Signals trans-
duced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing
vasculature, Cell 105 (2001) 863–875.
[5] A.M. Ranger, M.J. Grusby, M.R. Hodge, E.M. Gravallese, F.C. de la
Brousse, T. Hoey, C. Mickanin, H.S. Baldwin, L.H. Glimcher, The
transcription factor NF-ATc is essential for cardiac valve formation,
Nature 392 (1998) 186–190.
[6] A.M. Ranger, L.C. Gerstenfeld, J. Wang, T. Kon, H. Bae,
E.M. Gravallese, M.J. Glimcher, L.H. Glimcher, The nuclear factor of
activated T cells (NFAT) transcription factor NFATp (NFATc2) is a
repressor of chondrogenesis, J. Exp. Med. 191 (2000) 9–22.
[7] I.C. Ho, J.H. Kim, J.W. Rooney, B.M. Spiegelman, L.H. Glimcher, A
potential role for the nuclear factor of activated T cells family of
transcriptional regulatory proteins in adipogenesis, Proc. Natl. Acad.
Sci. USA 95 (1998) 15537–15541.
[8] N.A. Clipstone, G.R. Crabtree, Identification of calceniurin as a key
signalling enzyme in T cell activation, Nature 357 (1992) 695–697.
[9] C.R. Beals, C.M. Sheridan, C.W. Turck, P. Gardner, G.R. Crabtree,
Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3,
Science 275 (1997) 1930–1934.
[10] C.-H. Chow, M. Rincón, J. Cavanagh, M. Dickens, R.J. Davis,
Nuclear accumulation of NFAT4 opposed by the JNK signal transduc-
tion pathway, Science 278 (1997) 1638–1641.
Fig. 3. Characterisation of NFAT members in CD4+ T cells isolated from
the MedLN or lung of mice infected with influenza A or N. brasisliensis.
CD4+ T cells were isolated from the MedLN and lung of (A) Flu or (B) Nb
infected C57BL/6 mice and nuclear extracts made as described in Section 2.
DNA binding activity of NFAT transcription factors were examined using an
EMSA, and the characterisation of NFAT proteins as NFATc1 or NFATc2
determined by super-shift analysis using mAbs. DNA binding activity of
CREB proteins is shown as a control for protein loading. The data shown are
from nuclear extracts purified from pooled CD4+ T cells of 10–12 mice.
Similar results were obtained from two separate experiments.
236 N.L. Harris et al. / Microbes and Infection 8 (2006) 232–237
[11] C.W. Chow, C. Dong, R.A. Flavell, R.J. Davis, c-Jun NH(2)-terminal
kinase inhibits targeting of the protein phosphatase calcineurin to
NFATc1, Mol. Cell. Biol. 20 (2000) 5227–5234.
[12] P. Gomez del Arco, S. Martinez-Martinez, J.L. Maldonado, I. Ortega-
Perez, J.M. Redondo, A role for the p38 MAP kinase pathway in the
nuclear shuttling of NFATp, J. Biol. Chem. 275 (2000) 13872–13878.
[13] T.T. Yang, Q. Xiong, H. Enslen, R.J. Davis, C.W. Chow, Phosphory-
lation of NFATc4 by p38 mitogen-activated protein kinases, Mol.
Cell. Biol. 22 (2002) 3892–3904.
[14] J. Zhu, F. Shibasaki, R. Price, J.C. Guillemot, T. Yano, V. Dotsch,
G. Wagner, P. Ferrara, F. McKeon, Intramolecular masking of nuclear
import signal on NF-AT4 by casein kinase I and MEKK1, Cell 93
(1998) 851–861.
[15] J. Rengarajan, K.A. Mowen, K.D. McBride, E.D. Smith, H. Singh,
L.H. Glimcher, Interferon regulatory factor 4 (IRF4) interacts with
NFATc2 to modulate interleukin 4 gene expression, J. Exp. Med. 195
(2002) 1003–1012.
[16] F. Macian, C. Lopez-Rodriguez, A. Rao, Partners in transcription:
NFAT and AP-1, Oncogene 20 (2001) 2476–2489.
[17] J.D. Molkentin, J.-R. Lu, C.L. Antos, B. Markham, J. Richardson,
J. Robbins, S.R. Grant, E.N. Olson, A calcineurin-dependent tran-
scriptional pathway for cardiac hypertrophy, Cell 93 (1998) 215–226.
[18] S. Chuvpilo, E. Jankevics, D. Tyrsin, A. Akimzhanov, D. Moroz,
M.K. Jha, J. Schulze-Luehrmann, B. Santner-Nanan, E. Feoktistova,
T. Konig, A. Avots, E. Schmitt, F. Berberich-Siebelt, A. Schimpl,
E. Serfling, Autoregulation of NFATc1/A expression facilitates effec-
tor T cells to escape from rapid apoptosis, Immunity 16 (2002)
881–895.
[19] S. Chuvpilo, A. Avots, F. Berberich-Siebelt, J. Glockner, C. Fischer,
A. Kerstan, C. Escher, I. Inashkina, F. Hlubek, E. Jankevics,
T. Brabletz, E. Serfling, Multiple NF-ATc isoforms with individual
transcriptional properties are synthesized in T lymphocytes, J. Immu-
nol. 162 (1999) 7294–7301.
[20] S. Chuvpilo, M. Zimmer, A. Kerstan, J. Glockner, A. Avots, C. Escher,
C. Fischer, I. Inashkina, E. Jankevics, F. Berberich-Siebelt,
E. Schmitt, E. Serfling, Alternative polyadenylation events contribute
to the induction of NF-ATc in effector T cells, Immunity 10 (1999)
261–269.
[21] S. Diehl, C.W. Chow, L. Weiss, A. Palmetsofer, T. Twardzik,
L. Rounds, E. Serfling, R.J. Davis, J.Anguita, M. Rincon, Induction of
NFATc2 expression by interleukin 6 promotes T helper type 2 differ-
entiation, J. Exp. Med. 196 (2002) 39–49.
[22] E.M. Rainio, J. Sandholm, P.J. Koskinen, Transcriptional activity of
NFATc1 is enhanced by the Pim-1 kinase, J. Immunol. 168 (2002)
1524–1527.
[23] M. Rincon, R.A. Flavell, Transcription mediated by NFAT is highly
inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells,
Mol. Cell. Biol. 17 (1997) 1522–1534.
[24] J.W. Rooney, T. Hoey, L.H. Glimcher, Coordinate and cooperative
roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene,
Immunity 2 (1995) 473–483.
[25] J.M. Lumsden, J.M. Roberts, N.L. Harris, R.J. Peach, F. Ronchese,
Differential requirement for CD80 and CD80/CD86-dependent
co-stimulation in the lung immune response to an influenza virus
infection, J. Immunol. 164 (2000) 79–85.
[26] K. McCoy, M. Camberis, G.Le Gros, Protective immunity to nema-
tode infection is induced by CTLA-4 blockade, J. Exp. Med. 186
(1997) 183–187.
[27] S.L. Schreiber, M. Matthias, M. Müller, W. Shaffner, Rapid detection
of octamer binding proteins with ‘mini’-extracts prepared from a
small number of cells, Nucleic Acids Res. 17 (1989) 6419.
[28] J.W. Rooney, M.R. Hodge, P.G. McCaffrey, A. Rao, L.H. Glimcher, A
common factor regulates both Th1- and Th2-specific cytokine gene
expression, EMBO J. 13 (1994) 625–633.
[29] M.R. Montminy, M. Bilezikjian, Binding of nuclear protein to the
cyclic-AMP response element of the somatostatin gene, Nature 328
(1987) 175–178.
[30] M.C. Eichelberger, M.L. Wang, W. Allan, R.G. Webster, P.C. Doherty,
Influenza virus RNA in the lung and lymphoid tissue of immunologi-
cally intact and CD4-depleted mice, J. Gen. Virol. 72 (1991) 1695–
1698.
[31] J.A. Owen, L. Dudzik, L. Klein, D.R. Dorer, The kinetics of genera-
tion of influenza-specific cytotoxic T-lymphocyte precursor cells,
Cell. Immunol. 111 (1988) 247–252.
[32] K.J. Flynn, G.T. Belz, J.D. Altman, R. Ahmed, D.L. Woodland,
P.C. Doherty, Virus-specific CD8+ T cells in primary and secondary
influenza pneumonia, Immunity 8 (1998) 683–691.
[33] S. Sarawar, M. Sangster, R.L. Coffman, P.C. Doherty, Administration
of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice
delays influenza clearance but does not switch the response to a helper
cell 2 phenotype, J. Immunol. 153 (1994) 1246–1253.
[34] N. Baumgarth, A. Kelso, In vivo blockade of gamma interferon affects
the influenza virus-induced humoral and the local cellular immune
response in lung tissue, J. Virol. 70 (1996) 4411–4418.
[35] C. Huang, P. Mattjus, W.Y. Ma, M. Rincon, N.Y. Chen, R.E. Brown,
Z. Dong, Involvement of nuclear factor of activated T cells activation
in UV response. Evidence from cell culture and transgenic mice, J.
Biol. Chem. 275 (2000) 9143–9149.
[36] A.S. Stevemsom, M.F. Gomez, D.C. Hill-Eubanks, M.T. Nelson,
NFAT4 movement in native smooth muscle, J. Biol. Chem. 276 (2001)
15018–15024.
[37] J.F. Urban, K.B. Madden, A. Svetic, A. Cheever, P.P. Trotta,
W.C. Gause, I.M. Katona, F.D. Finkelman, The importance of
Th2 cytokines in protective immunity to nematodes, Immunol. Rev.
127 (1992) 205–220.
[38] N.L. Harris, R.J. Peach, F. Ronchese, CTLA4-Ig inhibits optimal T
helper 2 cell development but not protective immunity or memory
response to Nippostrongylus brasiliensis, Eur. J. Immunol. 29 (1999)
311–316.
[39] N.L. Harris, V. Watt, F. Ronchese, G. Le Gros, Differential T cell
function and fate in lymph node and nonlymphoid tissues, J. Exp.
Med. 195 (2002) 317–326.
237N.L. Harris et al. / Microbes and Infection 8 (2006) 232–237
